Emcure Pharmaceuticals L share price
EMCURE on NSE · data as of 16 Oct 2026
Emcure Pharmaceuticals L closed at ₹1,820.60 on 16 Oct 2026 (−0.84% on the day). It is 13.3% below its 52-week high of ₹2,100.70 (18 Sept 2026) and 40.1% above its 52-week low of ₹1,299.70 (3 Oct 2025). The stock has outperformed the Nifty 50 over the past year (+27.9% vs -8.5%). It is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 26 (oversold zone).
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | EMCURE | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | −0.7% | +2.8% | −3.5 pts |
| 1 month | −5.8% | −0.3% | −5.5 pts |
| 3 months | +2.1% | −4.9% | +7.0 pts |
| 6 months | +11.1% | −4.3% | +15.4 pts |
| 1 year | +27.9% | −8.5% | +36.4 pts |
Trend and activity
- 50-day average: ₹1,916.17 (price below)
- 200-day average: ₹1,706.17 (price above)
- RSI (14 days): 26
- Turnover on 16 Oct 2026: ₹7.2 cr (0.2x the 20-day average volume)
New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Emcure Pharmaceuticals L?
The 52-week high of Emcure Pharmaceuticals L (EMCURE) is ₹2,100.70, reached on 18 Sept 2026. The 52-week low is ₹1,299.70, on 3 Oct 2025 (NSE, as of 16 Oct 2026).
How has Emcure Pharmaceuticals L performed in the last year?
Over the last year the share price has moved +27.9%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.
Is Emcure Pharmaceuticals L in an uptrend?
As of 16 Oct 2026, Emcure Pharmaceuticals L is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 26 (oversold zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists